The prognostic value of N-ratio in patients with gastric cancer: Validation in a large, multicenter series

European Journal of Surgical Oncology

Volumn 34, Issue 2, 2008, Pages 159-165

  Marchet, A ^a   Mocellin, S ^a   Ambrosi, A ^a,b   de Manzoni, G ^c   Di Leo, A ^c   Marrelli, D ^d   Roviello, F ^d   Morgagni, P ^e   Saragoni, L ^e   Natalini, G ^f   De Santis, F ^g   Baiocchi, L ^h   Coniglio, A ^h   Nitti, D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e MORGAGNI PIERANTONI HOSPITAL   (Italy)

^f UNIVERSITY OF PERUGIA   (Italy)

^g Todi Marsciano General Hospital   (Italy)

^h UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Gastric cancer; N ratio; Prognosis; TNM staging system

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH CANCER;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; GASTRECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 38149088815     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.04.018     Document Type: Article

References (33)

1. Siewert J.R., Bittcher K., Stein H.J., and Roder J. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 228 (1998) 449-461
2. Bozzetti F., Bonfanti G., Morabito A., et al. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet 162 (1986) 229-234
3. Hohenberger P., and Gretschel S. Gastric Cancer. Lancet 362 (2003) 305-315
4. Dicken B.J., Bigam D.L., Cass C., et al. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 241 (2005) 27-39
5. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology. Part 1. Jpn J Surg 11 (1981) 127-139
6. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd English Edition. Gastric Cancer 1 (1981) 10-24
7. Sobin L.H., and Wittekind C.H. International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th ed. (1997), John Wiley & Sons, New York
8. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging manual. 6th ed. (2002), Springer-Verlag, New York
9. Bouvier A.M., Haas O., Piard F., et al. How many nodes must be examined to accurately stage gastric adenocarcinomas? Results from a population based study. Cancer 94 (2002) 2862-2866
10. Wanebo H.J., Kennedy B.J., Chmiel J., et al. Cancer of the stomach - a patient care evaluation study by the American College of Surgeons. Ann Surg 218 (1993) 583-592
11. Hundahl S.A., Macdonald J.S., Benedetti J., Fitzsimmons T., and for the Southwest Oncology Group and the Gastric Intergroup. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 9 (2002) 278-286
12. Wanebo H.J., Kennedy B.J., Winchester D.P., et al. Gastric carcinoma: does lymph node dissection alter the survival?. J Am Coll Surg 183 (1996) 616-624
13. Bonekamp J.J., Hermans J., Sasako M., et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 340 (1999) 908-914
14. Cuschieri A., Weeden S., Fielding J., et al. Patient survival after D1 and D2 resections for gastric cancer. Long term results of the MRC randomised surgical trial. Br J Cancer 79 (1999) 1522-1530
15. Jansen E.P., Boot H., Verheij M., et al. Optimal locoregional treatment in gastric cancer. J Clin Oncol 23 (2005) 4509-4517
16. Feinstein A.R., Sosin D.M., Wells C.K., and The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312 (1985) 1604-1608
17. Bonder B.E. Will Rogers and gastric carcinoma (letter). Arch Surg 123 (1988) 1023-1024
18. de Manzoni G., Verlato G., Roviello F., et al. The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer 87 (2002) 171-174
19. Bunt A.M.G., Hermans J., Smit V.T.H.B.M., et al. Surgical/pathologic-stage migration confronts comparisons of gastric cancer survival rate between Japan and Western countries. J Clin Oncol 13 (1995) 19-25
20. Bando E., Yonemura Y., Taniguchi K., et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9 (2002) 775-784
21. Inoue K., Nakane Y., Iiyama H., et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9 (2002) 27-34
22. Nitti D., Marchet A., Olivieri M., et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 10 (2003) 1077-1085
23. Hyung W.J., Noh S.H., Yoo C.H., et al. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 26 (2002) 323-329
24. Kodera Y., Yamamura Y., Shimizu Y., et al. Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM classification?. J Surg Oncol 69 (1998) 15-20
25. Therneau T.M., Grambsh P.M., and Flemming T.R. Martingale based residuals for survival models. Biometrika 77 (1990) 147-160
26. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
27. Cox D.R. Regression models and life-tables. J R Stat Soc B 34 (1972) 187-220
28. Grambsch P., and Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515-526
29. Vinh-Hung V., Vershraegen C., Promish D.I., et al. Ratios of involved nodes in early breast cancer. Breast Cancer Res 6 (2004) 680-688
30. Truong P.T., Berthelet E., Lee L., et al. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph. Cancer 103 (2005) 2006-2014
31. Berger A.C., Sigurdson E.R., LeVoyer T., et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23 (2005) 8706-8712
32. Cheong J.H., Hyung W.J., Shen J.G., et al. The N ratio predicts recurrence and poor prognosis in patients with node-positive early gastric cancer. Ann Surg Oncol 13 (2006) 377-385
33. Kunisaki C., Shimada H., Nomura M., et al. Clinical impact of metastatic lymph node ratio in advanced gastric cancer. Anticancer Res 25 (2005) 1369-1376